Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Macter International's gross profit for the
six
months ended in . 20 was ₨0.00 Mil. Macter International's gross profit for the trailing twelve months (TTM) ended in . 20 was ₨0.00 Mil.
Macter International (KAR:MACTER) Gross Profit Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Macter International had a gross margin of N/A% for the quarter that ended in . 20 => No sustainable competitive advantage
Macter International Gross Profit Related Terms
Macter International Gross Profit Historical Data
* Premium members only.
The historical data trend for Macter International's Gross Profit can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Macter International Gross Profit Chart
Macter International Annual Data
Trend
Gross Profit
Macter International Semi-Annual Data
Gross Profit
KAR:MACTER vs ZTS, UTHR, VTRS: Gross Profit Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Macter International's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Macter International Gross Profit vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Macter International's Gross Profit distribution charts can be found below:
* The bar in red indicates where Macter International's Gross Profit falls into.
For stock reported annually, GuruFocus uses latest annual data as the TTM data. Gross Profit for the trailing twelve months (TTM) ended in . 20 was ₨0.00 Mil.
Gross Profit is the numerator in the calculation of Gross Margin.
(Note that if there's no value for Cost of Goods Sold, then Gross Margin % is not calculated.)
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Macter International (KAR:MACTER) has a Gross Profit of ₨0.00 Mil as of . 20. Gross Profit equals net sales less total cost of goods sold. View historical data on Macter International and its competitors.
Is Macter International's Gross Profit too high?
Macter International's current Gross Profit is ₨0.00 Mil. Overall, Macter International has a GF Score™ of 2/100, reflecting its overall financial health beyond just this single metric.
How does Macter International's Gross Profit compare to ZTS and UTHR?
Macter International's Gross Profit of ₨0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Profit for a Drug Manufacturers company?
A good Gross Profit depends on the Drug Manufacturers industry context. However, Gross Profit should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Profit mean?
A high Gross Profit can signal that a stock is expensive relative to its fundamentals. Gross Profit equals net sales less total cost of goods sold. View historical data on Macter International and its competitors. Macter International's current Gross Profit is ₨0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Macter International stock overvalued right now?
Macter International (KAR:MACTER) has a current Gross Profit of ₨0.00 Mil. The current Gross Profit is ₨0.00 Mil. Macter International's overall GF Score™ is 2/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Profit calculated?
Gross Profit is calculated from a company's financial statements. For Macter International (KAR:MACTER), the current Gross Profit is ₨0.00 Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Macter International Ltd is engaged in the manufacturing and marketing of pharmaceutical products and formulations for healthcare companies in Pakistan. It is covering almost all therapeutic categories including Antibiotics, Anti-allergy, cardiovascular, Anti-viral, and many more.
2GF Score
Get the complete analysis for KAR:MACTER
Gross Profit is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
KAR:MACTER has been successfully added to your 
